|
|
Industriparken 55
Ballerup, DK 2750 Denmark
phone:(45) 4494 5888
fax:+45 7226 3321
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.leo-pharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Topical dermatology and parenteral treatment of thromboembolic disorders. |
|
| Management |
| Mrs. Gitte P. Aabo, President and CEO; Mr. Lars Olsen, Executive Vice President, Research & Development; Mr. Jens Bo Olesen, Executive Vice President, Sales & Marketing; Mr. John Mehlbye, Executive Vice President, Plants & Manufacturing
|
| |
|
|
| |
|
| Keywords |
| pharmaceutical, topical, dermatology, parenteral, thromboembolic, psoriasis, dermatitis, bacterial, skin, infections, eczema, acne, heparin |
|
|
|
| Description |
|
LEO Pharma is a globally, leading pharmaceutical company within Dermatology and Critical Care. LEO Pharma is an independent pharmaceutical company 100 % owned by the LEO Foundation and represented in more than 90 countries and has around 3,000 employees around the world; 1,200 of these in Ballerup, Denmark. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members